课题基金 / 基金详情

Molecular design and synthesis of HIV protease inhibitors with structurally constrained active conformation

Molecular design and synthesis of HIV protease inhibitors with structurally constrained active conformation
结构受限活性构象的HIV蛋白酶抑制剂的分子设计与合成
批准号:
08457588
负责人:
KISO Yoshiki
金额:
$4.16万
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (B)
财政年份:
1996
资助国家:
日本
项目状态:
已结题
起止时间:
1996 至 --

项目摘要

项目成果

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Based on the substrate-transition state concept of HIV protease inhibitors, we have succeeded to design, investigate the minimum site for enzyme-interaction and synthesize a highly selective and potent HIV protease inhibitor (KNI-272). These successful results are attributable to the analysis of enzyme-substrate (or-inhibitor) complexes focusing on enzyme reaction mechanism, and the molecular design of conformationally constrained mimics of substrate transition state in the enzyme active site. We further developed these methods to molecular design and synthesis of inhibitors with structurally constrained active conformation.1. Synthesis of mutant HIV protease.It has been already reported that in mutated HIV proteases 84-Ile is replaced with Val which interacts with Pl and Pl' subsites. Therefore we synthesized 84-Val HIV protease derivatives and examined the enzyme activity.2. Synthesis of active site derivatives of HIV proteases.HIV protease derivatives with isosteric amino acids at 25-Asp which participates in the interaction with the substrates. Since the HIV protease works as a dimer, we examined two types of combinations : native/isosteric and isosteric/isosteric.3. Synthesis of HIV protease inhibitors.Based on the substrate transition state concept, the amide bond of the cleavage sites, Phe-Pro and Tyr-Pro (Pl-Pl') characteristic to retroviral enzyme substrate was converted to the isosteric reduced-type, hydroxyethylene-type, dihydroxyethylene-type and others. Dipeptide derivatives with rigid structure were also synthesized.4. Conformational analysis of the enzyme-substrate complex was carried out by using NMR and molecular modeling.5. Fomation and analysis of enzyme-inhibitor complexes.X-ray crystallography and NMR analysis of the enzyme-inhibitor complex revealed that water molecules play an important role in the interaction of enzyme and inhibitors and that the highly potent inhibitor has highly constrained conformation.
期刊论文(18)
专著(0)
科研奖励(0)
会议论文
Yun-Xing Wang: "Solution NMR Evidence That the HIV-1 Protease Catalytic Aspartyl Groups Have Different Ionization States in the Complex Formed with the Asymmetric Drug KNI-272." Biochemistry. 35-31. 9945-9950 (1996)
Yun-Xing Wang:“溶液核磁共振证据表明,HIV-1 蛋白酶催化的天冬氨酰基团在与不对称药物 KNI-272 形成的复合物中具有不同的电离态。”
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Yoshiaki Kiso: "Disign and synthesis of substrate-based peptidomimetic HIV protease inhibitors containing the hydroxymethylcarbonyl isostere." Biopolymers. 40・2. 235-244 (1996)
Yoshiaki Kiso:“含有羟甲基羰基等排物的基于底物的拟肽 HIV 蛋白酶抑制剂的设计和合成”235-244。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
A.Kiriyama: "Binding characteristics of KNI-272 to plasma proteins, a new potent tripeptide HIV protease inhibitor." Bioharmaceut.Drug Disp.17-9. 735-751 (1996)
A.Kiriyama:“KNI-272 与血浆蛋白的结合特性,一种新型有效的三肽 HIV 蛋白酶抑制剂。”
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
11
    海外基金